Cryoapplication Versus Anti-VEGF Before Diabetic Vitrectomy
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
Pars-plana vitrectomy (PPV) is the cornerstone of surgical treatment for eyes with
complicated proliferative diabetic retinopathy. Anti-VEGF intravitreal injection before PPV
has shown a good effect on surgical outcomes. However, many patients present with
co-morbidities that contraindicate the usage of anti-VEGF in the pre-operative period. Thus,
cryoapplication, an old therapeutic tool for proliferative diabetic retinopathy may be a good
alternative. We present herein a comparative study between peripheral retinal cryoapplication
and anti-VEGF before vitrectomy for complicated proliferative diabetic retinopathy.